|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pre-gabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial显示文摘 | ROSENSTOCK J TUCHMAN M LAMOREAUX L | 2004 | Pain2004，110，3： | 1 |
| 2 | Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine (HOE 901)and NPH insulin显示文摘 | Donley DW Schwartz SL | 2001 | Diabetes Care2001，24，： | 1 |
| 3 | Basal insulin glargine in patients with type 1 diabetes:28-week comparison of insulin glagine(HOE 901)and NPH insulin显示文摘 | Rosenstock J Schwartz SL Clarkk CM Jr | 2001 | Diabetes Care2001，24，4： | 1 |
| 4 | A tandomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose lowering drugs in insulin-naive people with type 2 diabetes显示文摘 | Rosenstock J Davies M Home PD | 2008 | Diabetologia2008，51，： | 1 |
| 5 | Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine(HOE901) and NPH insulin显示文摘 | Rosenstock J Schwartz SL Clark CM Jr | 2001 | Diabetes Care2001，24，4： | 1 |
| 6 | Myeophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy:a double-blind randomized controlled trial显示文摘 | Frisch G Lin J Rosenstock J | | 0，，10： | 1 |
| 7 | A randomised,52week,treat-to-target trial comparing insulin detemir with insulin glargine when administered as add on to glucose-lowering drugs in insulin-naive people with type 2 diabetes显示文摘 | Rosenstock J Davies M Home PD | | 0，，： | 1 |
| 8 | Dose- ranging effects of canagliflozin,a sodium-glucose co- transporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes 显示文摘 | Rosenstock J Aggarwal N Polidori D | 2012 | 35 (6) : 1232- 12382012，35，6： | 1 |
| 9 | Dose-ranging effects of canagliflozin,a sodium-glucose co-transporter 2 inhibitor,as add-on to metformin in subjects with type 2 diabetes显示文摘 | Rosenstock J Aggarwal N Polidori D | 2012 | Diabetes Care2012，35，6： | 1 |
| 10 | Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1 -year study 显示文摘 | Rosenstock J Wilson C Fleck P | 2013 | Diabetes Obes Metab2013，15，10： | 1 |
| 11 | The Treat-to-TargetTrial: randomised addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients显示文摘 | RiddleMC Rosenstock J Gerich J | 2003 | Diabetes Care2003，26，11： | 1 |
| 12 | Basal insulin therapy in thpe 2 diaketes: 28-week comparison of insulin glargine (HOE901) and NPH insulin显示文摘 | Rosenstock J Schwartz SL Clark CM | 2001 | Diabetes Care2001，24，4： | 1 |
| 13 | Basal insulin therapy in typy 2 diabates: 27 -week comparison of insulin glargine ( HOE901 ) and NPH insulin 显示文摘 | Rosenstock J Schwartz S L Clark C Jr | 2001 | Diabetes Care2001，24，11： | 1 |
| 14 | Effect of saxagliptinmonotherapy in treatment-nai've patients with type 2 diabetes显示文摘 | Rosenstock J Aguilar-Salinas C Klein E | 2009 | CurrMed Res Opin2009，，： | 1 |
| 15 | Advancing insulin thera-py in type 2 diabetes previously treated with glargine plus oral agents :prandial premixed ( insulin lispro protamine suspension/li?pro) versusbasal/bolus ( glargine/lispro) therapy 显示文摘 | Rosenstock J Ahmann AJ Colon O | 2008 | Diabetes Care2008，31，1： | 1 |
| 16 | A randomised, 52-week, treat- to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes显示文摘 | Rosenstock J Davies M Home PD | 2008 | Diabetologia2008，51，3： | 1 |
| 17 | Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA ( 1C ) without causing weight gain or increased hypoglycaemia 显示文摘 | Rosenstock J Rendell MS Gross JL | 2009 | Diabetes Obes Metab2009，11，12： | 1 |
| 18 | Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the activecomparator CAROLINA trial显示文摘 | Rosenstock J Marx N Kahn S | 2013 | Diab Vasc Dis Res2013，10，4： | 1 |
| 19 | Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones,islet function,and postprandial glycemia in subjects with impaired glucose tolerance显示文摘 | Rosenstock J Foley J E Rendell M | 2008 | Diabetes Care2008，31，1： | 1 |
| 20 | Robust improvements in fasting and prandial measures of b - cell function with vildagliptin in drug- naive patients:analysis of pooled vildagliptin monotherapy database显示文摘 | Pratley R E Schweizer A Rosenstock J | 2008 | Diabetes Obes Metab2008，10，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员